These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31511189)

  • 1. Estimating the Marginal Productivity of the English National Health Service From 2003 to 2012.
    Lomas J; Martin S; Claxton K
    Value Health; 2019 Sep; 22(9):995-1002. PubMed ID: 31511189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local health care expenditure plans and their opportunity costs.
    Karlsberg Schaffer S; Sussex J; Devlin N; Walker A
    Health Policy; 2015 Sep; 119(9):1237-44. PubMed ID: 26251323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating a cost-effectiveness threshold for the Spanish NHS.
    Vallejo-Torres L; García-Lorenzo B; Serrano-Aguilar P
    Health Econ; 2018 Apr; 27(4):746-761. PubMed ID: 29282798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Government funding of the UK National Health Service: what does the historical record reveal?
    Appleby J
    J Health Serv Res Policy; 1999 Apr; 4(2):79-89. PubMed ID: 10387411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13.
    Martin S; Lomas J; Claxton K; Longo F
    Appl Health Econ Health Policy; 2021 Nov; 19(6):885-903. PubMed ID: 34286470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the marginal cost of a life year in Sweden's public healthcare sector.
    Siverskog J; Henriksson M
    Eur J Health Econ; 2019 Jul; 20(5):751-762. PubMed ID: 30796552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK budgetary systems and new health-care technologies.
    McGuire A; Litt M
    Value Health; 2003; 6 Suppl 1():S64-73. PubMed ID: 12846927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness in ambulatory care: alternative approaches.
    Angus DE; Auer L; Cloutier JE; Albert T
    J Ambul Care Manage; 1995 Jan; 18(1):29-38. PubMed ID: 10139344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing costs and outcomes across programmes of health care.
    Martin S; Rice N; Smith PC
    Health Econ; 2012 Mar; 21(3):316-37. PubMed ID: 21322086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of individual utility and social welfare.
    Dolan P
    J Health Econ; 1998 Jan; 17(1):39-52. PubMed ID: 10176314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing avoidable inequalities in health: a new criterion for setting health care capitation payments.
    Hauck K; Shaw R; Smith PC
    Health Econ; 2002 Dec; 11(8):667-77. PubMed ID: 12457368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17.
    Martin S; Claxton K; Lomas J; Longo F
    Health Policy; 2023 Jun; 132():104800. PubMed ID: 37004415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the aim of the English health care system to maximize QALYs?
    Shah K; Praet C; Devlin N; Sussex J; Appleby J; Parkin D
    J Health Serv Res Policy; 2012 Jul; 17(3):157-63. PubMed ID: 22767891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in unit costs of hospitals in the English National Health Service.
    Jacobs R; Dawson D
    J Health Serv Res Policy; 2003 Oct; 8(4):202-8. PubMed ID: 14596754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cured Today, Ill Tomorrow: A Method for Including Future Unrelated Medical Costs in Economic Evaluation in England and Wales.
    Perry-Duxbury M; Asaria M; Lomas J; van Baal P
    Value Health; 2020 Aug; 23(8):1027-1033. PubMed ID: 32828214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuing health outcomes: developing better defaults based on health opportunity costs.
    Ochalek J; Claxton K; Lomas J; Thompson KM
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):729-736. PubMed ID: 32954900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal cost per QALY estimates: What are they good for?
    Sampson C; Cookson G
    Health Policy; 2024 Apr; 142():105036. PubMed ID: 38447353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
    Woods B; Revill P; Sculpher M; Claxton K
    Value Health; 2016 Dec; 19(8):929-935. PubMed ID: 27987642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis and policy choices: investing in health systems.
    Murray CJ; Kreuser J; Whang W
    Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of expenditure variation in health care and care of the elderly among Finnish municipalities.
    Häkkinen U; Luoma K
    Health Econ; 1995; 4(3):199-211. PubMed ID: 7550770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.